Consult your provider for more information and medical advice on thyroid replacement therapy
The fiber has all night to absorb water and move through the colon
Lilly's TRIUMPH clinical program includes multiple Phase III trials evaluating retatrutide across different patient populations and endpoints: Seven additional Phase III readouts are expected throughout 2026, covering populations with type 2 diabetes, cardiovascular disease, obstructive sleep apnea, and other obesity-related comorbidities Cardiovascular outcomes data the gold standard for demonstrating that weight loss translates into reduced heart attacks, strokes, and cardiovascular death will be critical for retatrutide's regulatory and commercial positioning Head-to-head trials comparing retatrutide directly to existing therapies may provide definitive comparative efficacy data The Drug vs
Apple Health Optional read-only Apple Health connection for setup and daily context Optional read-only Apple Health support can include weight history, height, glucose readings, body composition, movement, workouts, calories, protein, water, carbs, fat, fiber and sugar
New studies are published, refining our understanding of its pharmacokinetics, pharmacodynamics, and potential applications